Clinical Trial Update: Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of Sofosbuvir + Ribavirin in adolescents and children with genotype 2 or 3 chronic hepatitis C infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sofosbuvir + Ribavirin (sofosbuvir; ribavirin)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C Virus Infection | Phase 2 | Status: COMPLETED | Results posted: 2019-04-30